20-63740489-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020062.4(SLC2A4RG):āc.239G>Cā(p.Gly80Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000179 in 1,229,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_020062.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A4RG | NM_020062.4 | c.239G>C | p.Gly80Ala | missense_variant | 2/8 | ENST00000266077.5 | NP_064446.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A4RG | ENST00000266077.5 | c.239G>C | p.Gly80Ala | missense_variant | 2/8 | 1 | NM_020062.4 | ENSP00000266077.2 | ||
SLC2A4RG | ENST00000474248.5 | n.247G>C | non_coding_transcript_exon_variant | 1/4 | 2 | |||||
SLC2A4RG | ENST00000485897.5 | n.110G>C | non_coding_transcript_exon_variant | 1/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000176 AC: 19AN: 1077744Hom.: 0 Cov.: 30 AF XY: 0.00000982 AC XY: 5AN XY: 509078
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2024 | The c.239G>C (p.G80A) alteration is located in exon 2 (coding exon 2) of the SLC2A4RG gene. This alteration results from a G to C substitution at nucleotide position 239, causing the glycine (G) at amino acid position 80 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at